anti-CD5-SPRD antibody product blog
Tags: Antibody; Monoclonal Antibody; CD5-SPRD; anti-CD5-SPRD antibody;
The CD5-SPRD n/a (Catalog #MBS670373) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Mouse Anti-Human CD5-SPRD reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CD5-SPRD can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry, Immunohistochemistry (Frozen sections), Western Blot, Immunoprecipitation.Flow Cytometry: 10 uL/10^6 cells. Researchers should empirically determine the suitability of the CD5-SPRD n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Characterization: To insure lot to lot consistency, each batch of product is tested by flow cytometry to conform to the characteristics of a standard reference reagent. Warning: Reagents contain sodium azide which is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD5-SPRD are readily searchable from our website. Different antibodies against the same target such as CD5-SPRD may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.